Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02844504 : Neurophysiological Evaluation of Training Effect on Cancer-Related Weakness
PhaseN/A
AgesMin: 50 Years Max: 75 Years
Eligibility
Inclusion Criteria:

- Female aged 50-75 yrs

- Right handed, as determined by the Edinburgh Inventory (Oldfield, 1971)

- Proficient in English

- Must be available for the familiarization, and testing sessions

Exclusion Criteria:

- Symptoms for mild or severe depression as determined by a Patient Health
Questionnaire (PHQ-8) score >14

- Significant cognitive impairments as defined by a score <28 in the Folstein
Mini-Mental Screening Examination (MMSE, Folstein et al .1975).

- Participated in any type of motor imagery or strength training program in the last 5
years, or plan to start any motor imagery or physical strength training program for
the 3 months duration of the study

- Neurological, psychiatric, musculoskeletal or other types of disorder that may affect
participants sensorimotor function and cognitive abilities

- Current medication believed to affect cognitive/psychomotor function (i.e., opioid,
analgesics, anxiolytics or antidepressants)

- History of alcohol, smoking, and drug abuse

- Any contraindication for MRI
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02844504      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740